Literature DB >> 3148240

Conservation of antigenicity in a 31-kDa Brucella protein.

B J Bricker1, L B Tabatabai, B L Deyoe, J E Mayfield.   

Abstract

A 31-kilodalton (kDa) protein extracted from Brucella abortus was previously cloned into Escherichia coli and expressed at high levels. The E. coli-derived protein can be purified by a simple 2-step procedure entailing detergent extraction followed by ion-exchange chromatography. Subsequent analyses show that the E. coli-derived protein is identical to the Brucella-derived protein in molecular weight and isoelectric point. A partial amino acid sequence of the N-terminus of the protein of E. coli origin matches the predicted sequence, based on DNA sequence data. Using specific antiserum raised against the E. coli-derived protein, 34 strains of Brucella, representing all 6 recognized species, were examined for expression of the 31-kDa protein by Western blotting. This protein was detectable in all, but one Brucella species (B. ovis), including all 8 biovars of B. abortus tested. This degree of conservation supports further study of the 31-kDa protein for potential exploitation as a vaccine or diagnostic component.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3148240     DOI: 10.1016/0378-1135(88)90096-x

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  17 in total

1.  Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus.

Authors:  T J Stabel; J E Mayfield; L B Tabatabai; M J Wannemuehler
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

2.  Soluble expression and purification of Brucella cell surface protein (BCSP31) of Brucella melitensis and preparation of anti-BCSP31 monoclonal antibodies.

Authors:  Lei Zhang; Xing An Wu; Fang Lin Zhang; Cui Hong An; Yang Xin Sun; Wen Tao Bai; Zhi Kai Xu
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

3.  Differentiation between active and inactive human brucellosis by measuring antiprotein humoral immune responses.

Authors:  F A Goldbaum; C P Rubbi; J C Wallach; S E Miguel; P C Baldi; C A Fossati
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

4.  Cloning, expression, and occurrence of the Brucella Cu-Zn superoxide dismutase.

Authors:  B J Bricker; L B Tabatabai; B A Judge; B L Deyoe; J E Mayfield
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

5.  Polymorphism in Brucella spp. due to highly repeated DNA.

Authors:  S M Halling; E S Zehr
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

6.  Alteration of protective and serologic responses in BALB/c mice vaccinated with chemically modified versus nonmodified proteins of Brucella abortus 19.

Authors:  G W Pugh; L B Tabatabai
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Deletion of the BCSP31 gene of Brucella abortus by replacement.

Authors:  S M Halling; P G Detilleux; F M Tatum; B A Judge; J E Mayfield
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

8.  Swine immunity to an attenuated Salmonella typhimurium mutant containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus.

Authors:  T J Stabel; J E Mayfield; L B Tabatabai; M J Wannemuehler
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

9.  Immunogenicity of Actinobacillus pleuropneumoniae outer membrane proteins and enhancement of phagocytosis by antibodies to the proteins.

Authors:  R N Thwaits; S Kadis
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

10.  Variation of Brucella abortus 2308 infection in BALB/c mice induced by prior vaccination with salt-extractable periplasmic proteins from Brucella abortus 19.

Authors:  G W Pugh; L B Tabatabai
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.